Immunic
IMUX
IMUX
68 hedge funds and large institutions have $114M invested in Immunic in 2021 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 31 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.57% more ownership
Funds ownership: 4.34% → 4.9% (+0.57%)
2% less capital invested
Capital invested by funds: $116M → $114M (-$1.77M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
68
Holding in Top 10
–
Calls
$763K
Puts
$194K
Top Buyers
| 1 | +$6.15M | |
| 2 | +$5.02M | |
| 3 | +$4.43M | |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$3.84M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$2.95M |
Top Sellers
| 1 | -$1.25M | |
| 2 | -$575K | |
| 3 | -$373K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$146K |
| 5 |
Two Sigma Investments
New York
|
-$139K |